Delivery Order SPE2DB20D1109-SPE2DB23FP45W
Award Date 7/5/23
Potential Completion Date 7/6/23
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
- This federal contract award, valued at $1,377.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,172,639 units of Vyvanse 60 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,486.46 firm-fixed-price delivery order contract is for the supply of 4,567,299,122 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,760.92 for the supply of 4,568,165,093 units of Vyvanse 50 mg capsules. The contract has a period of performance extending through May 7, 2025 and is a Firm Fixed Price, non-set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,274.99 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,565,442,423 units of the 20 mg Vyvanse capsule medication. The contract has an ultimate completion date of August 14, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian agencies, including an Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed-price delivery order contract worth $3,817.72 for 4,563,962,745 units of the pharmaceutical product Vyvanse 10 mg capsules. The contract has a period of performance through March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is likely part of a larger indefinite delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $20,143.11, is for the delivery of 4,561,037,211 units of Vyvanse Capsules 30mg. The contract has a firm fixed price pricing type and a completion date of May 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,838.56 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,734,299 units of the prescription medication Vyvanse (60mg capsules) over a period ending on May 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, serving as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,326.52 delivery order is for the supply of 4,568,235,937 units of Vyvanse 10 mg capsules. The contract has a firm fixed-price, non-set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $2,435.59, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,170,540 units of the medication Vyvanse 20mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a larger indefinite delivery...